Skip to main content

Table 1 Patient characteristics of the two groups

From: Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy

Variables

AAN(n = 42)

NON-AAN(n = 238)

P Value

Age (year)

68.0 (52–81)

67.2 (32–79)

0.62

Gender, n (%)

  

< 0.001

 Male

11 (26.2)

142 (59.7)

 

 Female

31 (73.8)

96 (40.3)

 

End-stage renal disease

  

< 0.001

 Yes

14 (33.3)

11 (4.6)

 

 No

28 (66.7)

227 (95.4)

 

Tumor location, n (%)

  

0.89

 Renal pelvis

23 (54.7)

112 (62.7)

 

 Ureter

19 (45.3)

126 (37.3)

 

 Upper

4 (23.1)

36 (29.0)

 

 Middle

9 (46.2)

60 (47.4)

 

 Lower

6 (30.7)

30 (23.6)

 

Previous bladder tumor n (%)

  

0.40

 Yes

5 (11.9)

21 (9.3)

 

 No

37 (88.1)

217 (91.7)

 

Hydronephrosis

   

 Yes

27 (64.3)

156 (65.5)

0.87

 No

15 (35.7)

82 (34.5)

 

pT stage, n (%)

  

0.79

 pTa

1 (2.4)

7 (2.8)

 

 pT1

19 (45.2)

109 (45.8)

 

 pT2

15 (35.7)

86 (36.1)

 

 pT3

4 (9.5)

26 (11.1)

 

 pT4

3 (7.2)

10 (4.2)

 

pN stage, n (%)

  

0.12

 pN0

38 (90.7)

205 (86.1)

 

 pN1

4 (9.3)

33 (13.9)

 

Grade, n (%)

  

0.11

 Low

18 (42.8)

102 (43.1)

 

 High

24 (57.1)

136 (56.9)

 

Surgical approach, n (%)

  

0.40

 Laparoscopic

36 (85.7)

212 (89.1)

 

 Open

6 (14.3)

26 (10.9)

 

Mean operative time (min)

142.3 ± 26.4

146.0 ± 32.5

0.31

Mean estimate blood loss (ml)

207.8 ± 78.3

194.5 ± 90.0

0.06

Complications (Clavien Grade), n (%)

  

0.003

 None

20 (47.6)

163 (68.5)

 

 1

11 (26.2)

43 (18.1)

 

 2

7 (16.7)

28 (11.8)

 

 3

1 (2.4)

3 (1.3)

 

 4

3 (7.1)

1 (0.4)

 

 5

0 (0)

0 (0)

Â